விட்ரோ நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விட்ரோ நுட்பங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விட்ரோ நுட்பங்கள் Today - Breaking & Trending Today

Hemostemix Inc.: Hemostemix Announces Closing of First Tranche of Unit Private Placement

Hemostemix Inc.: Hemostemix Announces Closing of First Tranche of Unit Private Placement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Thomas Smeenk , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Alberta Newsfile Corp , Venture Exchange , Company Common Share , Each Unit , Common Share , Common Shares , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Neural Lineage , Automated Cell , Looking Information , ஒன்றுபட்டது மாநிலங்களில் , ஒழுங்குமுறை சேவை வழங்குநர் , பொதுவானது பங்குகள் ஆஃப் தி நிறுவனம் , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , துணிகர பரிமாற்றம் , நிறுவனம் பொதுவானது பகிர் ,

Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension

Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension
Calgary, Alberta (Newsfile Corp. - July 5, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ( Hemostemix or the Company ) is pleased to announce, subject to TSX Venture Exchange Approval, that it has extended for two years and repriced to $0.55 from $1, subject to the accelerator provisions stated below on all repriced warrants, 1,332,500 Warrants expiring July 9, 2021; extended 918,450 Warrants expiring November 24, 2021 of which 510,295 Warrants are repriced to $0.55 (408,155 Warrants held by insiders not repriced from $1); extended 6,360,585 Warrants expiring December 18, 2021, repricing 4,733,559 Warrants (1,627,026 Warrants held by insiders are not repriced from $1); extended 9,166,667 Warrants expiring December 31, 2021, repricing 8,513,334 Warrants (653,333 Warrants held by insiders not repriced from $1). ....

United States , Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Company Counsel , Venture Exchange Approval , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Exchange Approval , Multilateral Instrument , Minority Shareholders , Special Transactions , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , Looking Information , Common Shares , ஒன்றுபட்டது மாநிலங்களில் , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , நிறுவனம் ஆலோசனை ,

Hemostemix to Present at the Emerging Growth Conference

Hemostemix to Present at the Emerging Growth Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Wall Street , Emerging Growth Conference , Emerging Growth , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , Looking Information , Debenture Warrants , Common Shares , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , ஒழுங்குமுறை சேவை வழங்குநர் , துணிகர பரிமாற்றம் , சுவர் தெரு , வளர்ந்து வருகிறது வளர்ச்சி மாநாடு , வளர்ந்து வருகிறது வளர்ச்சி ,

Hemostemix Inc.: Hemostemix to Present at the Emerging Growth Conference

Hemostemix Inc.: Hemostemix to Present at the Emerging Growth Conference
Hemostemix or the
Company ) is pleased to announce that it will present live at the Emerging Growth Conference on May 26, 2021 from 3:30 - 4:00 ET and it invites shareholders, individual and institutional investors, as well as advisors and analysts to attend its real-time, interactive presentation.
Attendees are invited to register here to ensure you are able to attend the conference and receive any updates that are released.
ABOUT EMERGING GROWHT CONFERENCE
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner. ....

Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Emerging Growth Conference , Emerging Growth , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , Looking Information , Debenture Warrants , Common Shares , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , ஒழுங்குமுறை சேவை வழங்குநர் , துணிகர பரிமாற்றம் , வளர்ந்து வருகிறது வளர்ச்சி மாநாடு , வளர்ந்து வருகிறது வளர்ச்சி , தண்டு செல் சிகிச்சை , விட்ரோ நுட்பங்கள் ,

Hemostemix Inc.: Hemostemix Announces Closing of Unit Private Placement

Hemostemix Inc.: Hemostemix Announces Closing of Unit Private Placement
Hemostemix or the
Units ) announced on April 9, 2021, for gross proceeds of $440,031.90 (the
Offering ). The Offering consisted of the issuance of an aggregate of 1,257,234 Units at a price of $0.35 per Unit. Each Unit consists of one common share in the capital of the Company (
Common Share ) and one transferable common share purchase warrant (
Warrant ), with each full Warrant entitling the holder to acquire one Common Share at a price of $0.40 per Common Share for a period of 24 months from the closing of the Offering, subject to the accelerated expiry provision described below. ....

United States , Thomas Smeenk , Regulation Service Provider , Common Shares Of The Company , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Alberta Newsfile Corp , Venture Exchange , Company Common Share , Each Unit , Common Share , Common Shares , Multilateral Instrument , Minority Security Holders , Special Transactions , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , ஒன்றுபட்டது மாநிலங்களில் , ஒழுங்குமுறை சேவை வழங்குநர் , பொதுவானது பங்குகள் ஆஃப் தி நிறுவனம் ,